Strategia Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2012)

Organization Overview

First Clinical Trial
2015
NCT02418000
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Strategia Therapeutics | Vitrac Therapeutics, LLC